200 related articles for article (PubMed ID: 36964244)
1. Molecular recognition of SARS-CoV-2 spike protein with three essential partners: exploring possible immune escape mechanisms of viral mutants.
Cheng Y; Zheng D; Zhang D; Guo D; Wang Y; Liu W; Liang L; Hu J; Luo T
J Mol Model; 2023 Mar; 29(4):109. PubMed ID: 36964244
[TBL] [Abstract][Full Text] [Related]
2. Altered hACE2 binding affinity and S1/S2 cleavage efficiency of SARS-CoV-2 spike protein mutants affect viral cell entry.
Wang K; Pan Y; Wang D; Yuan Y; Li M; Chen Y; Bi L; Zhang XE
Virol Sin; 2023 Aug; 38(4):595-605. PubMed ID: 37343929
[TBL] [Abstract][Full Text] [Related]
3. Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease.
Stevaert A; Van Berwaer R; Mestdagh C; Vandeput J; Vanstreels E; Raeymaekers V; Laporte M; Naesens L
mBio; 2022 Aug; 13(4):e0137622. PubMed ID: 35913162
[TBL] [Abstract][Full Text] [Related]
4. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity.
Khatri R; Siddqui G; Sadhu S; Maithil V; Vishwakarma P; Lohiya B; Goswami A; Ahmed S; Awasthi A; Samal S
Med Microbiol Immunol; 2023 Feb; 212(1):103-122. PubMed ID: 36583790
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Omicron Specific Mutations Affecting Infectivity, Fusogenicity, and Partial TMPRSS2-Independency.
Strobelt R; Broennimann K; Adler J; Shaul Y
Viruses; 2023 May; 15(5):. PubMed ID: 37243215
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics simulations of the spike trimeric ectodomain of the SARS-CoV-2 Omicron variant: structural relationships with infectivity, evasion to immune system and transmissibility.
de Souza AS; Amorim VMF; de Souza RF; Guzzo CR
J Biomol Struct Dyn; 2023 Nov; 41(19):9326-9343. PubMed ID: 36345794
[TBL] [Abstract][Full Text] [Related]
8. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
[TBL] [Abstract][Full Text] [Related]
9. In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor.
Zhang Y; He X; Zhai J; Ji B; Man VH; Wang J
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34013346
[TBL] [Abstract][Full Text] [Related]
10. Investigation on the interaction mechanism of different SARS-CoV-2 spike variants with hACE2: insights from molecular dynamics simulations.
Wu J; Zhang HX; Zhang J
Phys Chem Chem Phys; 2023 Jan; 25(3):2304-2319. PubMed ID: 36597957
[TBL] [Abstract][Full Text] [Related]
11. Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2.
Hu B; Chan JF; Liu H; Liu Y; Chai Y; Shi J; Shuai H; Hou Y; Huang X; Yuen TT; Yoon C; Zhu T; Zhang J; Li W; Zhang AJ; Zhou J; Yuan S; Zhang BZ; Yuen KY; Chu H
Emerg Microbes Infect; 2022 Dec; 11(1):2275-2287. PubMed ID: 36039901
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 evolution influences GBP and IFITM sensitivity.
Mesner D; Reuschl AK; Whelan MVX; Bronzovich T; Haider T; Thorne LG; Ragazzini R; Bonfanti P; Towers GJ; Jolly C
Proc Natl Acad Sci U S A; 2023 Jan; 120(5):e2212577120. PubMed ID: 36693093
[TBL] [Abstract][Full Text] [Related]
13. In silico analysis of mutations near S1/S2 cleavage site in SARS-CoV-2 spike protein reveals increased propensity of glycosylation in Omicron strain.
Beaudoin CA; Pandurangan AP; Kim SY; Hamaia SW; Huang CL; Blundell TL; Vedithi SC; Jackson AP
J Med Virol; 2022 Sep; 94(9):4181-4192. PubMed ID: 35575289
[TBL] [Abstract][Full Text] [Related]
14. Omicron variant receptor-binding domain phylogenetics and molecular dynamics.
Kandeel M; El-Deeb W
Comput Biol Med; 2022 Jul; 146():105633. PubMed ID: 35605487
[TBL] [Abstract][Full Text] [Related]
15. Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein.
Yamamoto M; Gohda J; Kobayashi A; Tomita K; Hirayama Y; Koshikawa N; Seiki M; Semba K; Akiyama T; Kawaguchi Y; Inoue JI
mBio; 2022 Aug; 13(4):e0051922. PubMed ID: 35708281
[TBL] [Abstract][Full Text] [Related]
16. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
Frolova EI; Palchevska O; Lukash T; Dominguez F; Britt W; Frolov I
J Virol; 2022 Aug; 96(15):e0075322. PubMed ID: 35876526
[TBL] [Abstract][Full Text] [Related]
17. Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodies.
Guo D; Duan H; Cheng Y; Wang Y; Hu J; Shi H
Mol Biomed; 2022 Apr; 3(1):12. PubMed ID: 35461370
[TBL] [Abstract][Full Text] [Related]
18. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
Zhan W; Tian X; Zhang X; Xing S; Song W; Liu Q; Hao A; Hu Y; Zhang M; Ying T; Chen Z; Lan F; Sun L
J Virol; 2022 Aug; 96(16):e0048022. PubMed ID: 35924918
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity.
Sasaki M; Toba S; Itakura Y; Chambaro HM; Kishimoto M; Tabata K; Intaruck K; Uemura K; Sanaki T; Sato A; Hall WW; Orba Y; Sawa H
mBio; 2021 Aug; 12(4):e0141521. PubMed ID: 34425707
[TBL] [Abstract][Full Text] [Related]
20. Computational prediction of the effect of mutations in the receptor-binding domain on the interaction between SARS-CoV-2 and human ACE2.
Celik I; Khan A; Dwivany FM; Fatimawali ; Wei DQ; Tallei TE
Mol Divers; 2022 Dec; 26(6):3309-3324. PubMed ID: 35138508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
